Kadiant LLC

BigHat Biosciences is a biotech company based in San Carlos, CA, specializing in the design of safer and more effective antibody therapies for patients. They utilize machine learning and synthetic biology to develop next-generation treatments for challenging diseases, integrating a wet lab for high-speed characterization with state-of-the-art technology. With a high-performance culture of excellence, BigHat has a pipeline of wholly-owned and partnered therapeutic programs. They have raised $100M from top investors and are committed to creating innovative antibody therapies through their expertise in machine learning and synthetic biology.Generated from the website

Attralus, Inc is a San Francisco-based biotechnology company that is dedicated to developing innovative therapeutics for systemic amyloidosis. Their groundbreaking pan-amyloid removal (PAR) approach aims to directly bind and eliminate toxic amyloid, offering potential treatment options for all types and stages of this debilitating disease. With a mission to improve the lives of patients with systemic amyloidosis, Attralus is focused on developing transformational therapeutics that target the underlying disease. Their proprietary technology enables the development of novel biologics and the world's first amyloidosis-specific imaging agent, propelling their strategy to identify and treat all stages and types of patients with this life-threatening condition.Generated from the website